Analysis of Postoperative Recurrence in Stage I–III Midgut Neuroendocrine Tumors

Well-Differentiated Neuroendocrine Neoplasia: Relapse-Free Survival and Predictors of Recurrence after Curative Intended Resections

(2014) P. Dieckhoff et al.   DIGESTION

Gastrointestinal carcinoid: epidemiological and survival evidence from a large population-based study (n = 25 531)

(2013) S. Mocellin et al.   ANNALS OF ONCOLOGY

Neuroendocrine tumor disease: an evolving landscape

(2012) Andrea Frilling et al.   ENDOCRINE-RELATED CANCER

Prognostic Validity of the American Joint Committee on Cancer Staging Classification for Midgut Neuroendocrine Tumors

(2012) Jonathan R. Strosberg et al.   JOURNAL OF CLINICAL ONCOLOGY

Relapse factors for ileal neuroendocrine tumours after curative surgery: A retrospective French multicentre study

(2011) Catherine Le Roux et al.   DIGESTIVE AND LIVER DISEASE

Elevated Plasma Chromogranin A Is the First Indication of Recurrence in Radically Operated Midgut Carcinoid Tumors

(2009) Staffan Welin et al.   NEUROENDOCRINOLOGY

One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

(2008) James C. Yao et al.   JOURNAL OF CLINICAL ONCOLOGY

The Secret of Immortal Time Bias in Epidemiologic Studies

(2008) S. Z. Shariff et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY